Jiangsu Hansoh Pharmaceutical Group Co., Ltd – FDA 483, Apr 24, 2026
Jiangsu Hansoh Pharmaceutical Group Co. Ltd. in Lianyungang, Jiangsu, was inspected regarding its sterile drug manufacturing operations. The inspection revealed significant deficiencies across multiple areas, including inadequate validation of sterilization processes, insufficient investigation into discrepancies and complaints, and failures in environmental monitoring and equipment calibration. These issues indicate a lack of robust controls to prevent microbiological contamination and ensure product quality and sterility.
ID · bac320eb-cc86-4760-bb4b-a055b0e5125b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.